Search results
Michael R Tadross. Duke University, Pratt School of Engineering. Verified email at duke.edu - Homepage. Biomedical Engineering & Neuroscience. Title. Sort. Sort by citations Sort by year Sort...
Michael Tadross, MD, PhD, is an Assistant Professor of Biomedical Engineering and Neurobiology at Duke University, where he develops genetically encoded technologies to target clinically relevant drugs to specific cell types in the brain.
Michael Tadross. Assistant Professor of Biomedical Engineering at Duke University. I received a B.S. in Electrical & Computer Engineering with a minor in Chemistry at Rutgers; an M.D.-Ph.D. in Biomedical Engineering at Johns Hopkins; and postdoctoral training in Cellular Neuroscience at Stanford.
Oct 18, 2018 · Michael Tadross is using novel approaches to tease out the causes of neuropsychiatric diseases at a cellular level. Current methods such as gene editing and pharmacology can reveal how certain genes and drugs affect the cells in a given area of the brain, but they’re limited in that they don’t account for differences among different cell types.
Oct 27, 2019 · Michael Tadross, MD, is an assistant professor in Duke BME, where his lab uses a novel technology dubbed DART, or Drugs Acutely Restricted by Tethering, to deliver pharmaceuticals to specific cells within the brain.
Assistant Professor of Biomedical Engineering. Dr. Tadross' lab develops technologies to rapidly deliver drugs to genetically defined subsets of cells in the brain.
Apr 7, 2017 · Luke D. Lavis, Michael R. Tadross† INTRODUCTION: Animal behavior is medi-ated by molecular, cellular, and circuit com-ponents of the brain. However, because many proteins are broadly expressed, it has been dif-ficult to link the activity of specific proteins in defined cells to behavioral roles. This challenge has particular relevance to neu-
